Thomas Finnerty - 09 Mar 2022 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Mar 2022, 16:36:20 UTC
Prior SEC filing
28 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas Finnerty

Key filing fact

Thomas Finnerty filed Form 4 for Anika Therapeutics, Inc. (ANIK) on 11 Mar 2022.

Key facts

  • This page summarizes Thomas Finnerty's Form 4 filing for Anika Therapeutics, Inc. (ANIK).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 11 Mar 2022, 16:36.

Change

  • Previous filing in this sequence was filed on 28 Feb 2022.
  • Current net transaction value: -$19,613.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIK transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+2,548
Change %
+11%
Price
$0.000000
Shares after
25,346
Date
09 Mar 2022
Ownership
Direct
Footnotes
F1
ANIK transaction

Common Stock

Tax liability

Transaction value
$19,613
Shares
-748
Change %
-3%
Price
$26.22
Shares after
24,598
Date
09 Mar 2022
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANIK transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-2,548
Change %
-33%
Price
$0.000000
Shares after
5,097
Date
09 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,548
Exercise price
$0.000000
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.

Footnote F2

Reflects an aggregate of 748 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2022.

Footnote F3

Reflects the closing price of ANIK common stock on March 9, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.

Footnote F4

Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .